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Abstract
OBJECTIVE: Human papillomavirus (HPV) infections have been discussed with 
regard to laryngeal carcinogenesis in recent years. This study investigated the 
presence of HPV in larynx squamous cell carcinomas (SCC) via immunohisto-
chemistry and polymerase chain reaction (PCR) array hybridization method and 
the relationship between p53 and Ki-67 expression with HPV presence and clin-
icopathological parameters.
MATERIALS AND METHODS: A total of 47 patients who had been operated on 
for larynx SCC were retrospectively included in the study. PanHPV, HPV-16, HPV-
18, p53, and Ki-67 immunohistochemical stains were applied to cross-sections 
obtained from wax blocks by means of an avidin-biotin complex system. DNA 
was isolated from the cross-sections. The presence of HPV was investigated via 
the HybriBio HPV GenoArray diagnostic kit.
RESULTS: Polyclonal HPV positivity was detected only in 15 (31.9%) cases by 
means of PCR array hybridization method. Contrary to the literature, HPV-68 was 
found in two cases. In HPV (PCR)-positive cases, Ki-67 staining was found at high 
grade (p=0.01). The expression of p53 (p=0.041) increased as differentiation 
decreased in tumors. When comparing Ki-67, panHPV (p=0.004), and HPV-16 
(p=0.002) staining, the expression of Ki-67 was higher than others in positive 
cases.
CONCLUSION: Formalin-fixed paraffin-embedded tissues can be used to indi-
cate the presence of HPV. The use of the HybriBio HPV GenoArray test was much 
more straightforward than other methods and is useful in detecting HPV DNA. 
In the literature, no HPV-68 virus was detected in larynx SCCs until recently. The 
expression of Ki-67 and p53 could be central to the prognosis in larynx SCCs.
KEYWORDS: Human papillomavirus, larynx, PCR, p53, Ki-67, immunohisto-
chemistry
Özet
AMAÇ: Larinks kanseri gelişiminde son yıllarda Human Papillomavirüs (HPV) 
enfeksiyonları üzerinde durulmaktadır. Bu çalışmada larinks Skuamöz hücreli 
karsinom (SHK)’larında HPV varlığının immünohistokimyasal ve Polimeraz zin-
cir reaksiyonu (PZR) dizisi hibrizasyon yöntemiyle araştırılması, ayrıca p53, Ki-67 
ekspresyonunun HPV varlığı ve klinikopatolojik parametrelerle ilişkisinin ortaya 
konması amaçlanmıştır.
GEREÇ VE YÖNTEMLER: Larinks SHK nedeniyle opere edilen 47 olgu retrospek-
tif olarak çalışmaya alındı. Parafinli bloklardan hazırlanan kesitlere Avidin-Biyotin 
kompleks sistemiyle panHPV, HPV-16, HPV-18, p53 ve Ki-67 immünohistokimya-
sal boyaları uygulandı. Parafin bloklardan hazırlanan kesitlerden DNA izolasyonu 
yapıldı. Sonrasında HPV varlığı HybriBio HPV Genoarray Test ile araştırıldı.
BULGULAR: PZR-array hibridizasyon yöntemi ile olguların 15’inde (%31,9) po-
liklonal HPV pozitifliği saptanmıştır. İki olguda literatürden farklı olarak HPV 68 
bulunmuştur. HPV (PZR) pozitif bulunan olgularda anlamlı düzeyde yüksek Ki-
67 boyanması (p=0,01) saptanmıştır. Tümörlerde diferansiyasyon azaldıkça p53 
(p=0,041) ekspresyonunun arttığı görülmüştür. Ki-67 ile panHPV (p=0,004) ve 
HPV-16 (p=0,002) boyanması karşılaştırıldığında, pozitif olgularda Ki-67 eks-
presyonunun yüksek olduğu gözlenmiştir.
SONUÇ: Formalin fikse parafine gömülü dokular HPV varlığının gösterilme-
sinde kullanılabilir. HybriBio HPV Genoarray test metodu diğer metodlara göre 
kullanımı oldukça basittir ve HPV-DNA saptanmasında kıymetli bir araç olabilir. 
Literatür araştırıldığında şimdiye kadar HPV 68 virüsünün larinks SHK’larında 
saptanmadığı görülmüştür. Ki-67 ve p53 ekspresyonları larinks SHK’larında iyi 
veya kötü prognoz açısından yol gösterici olabilir.
ANAHTAR KELİMELER: Human papillomavirüs, larinks, PZR, p53, Ki-67, immü-
nohistokimya
Larinks Primer Skuamöz Hücreli Karsinomlarında Human Papillomavirüs Sıklığı, P53 ve Ki-67 
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Introduction
Laryngeal cancer is the most common form of cancer in the head 
and neck area and constitutes 2% of all cancers in adults (1). The inci-
dence varies between different countries and has shown an increas-
ing trend in many studies (2). Ninety percent of tumor cases are squa-
mous cell carcinomas (SCCs), and the main predisposing factors are 
smoking and alcohol. Viral infections, malnutrition, and local dietary 
habits are also factors in the etiology of laryngeal cancer (3). 
Human papillomavirus (HPV) is a small DNA virus of the family Pa-
povaviridae, which generally infects squamous cells. More than 100 
types of HPV have been defined (4). Biomolecular studies reveal that 
specific mechanisms play roles in HPV-based carcinogenesis, and it is 
assumed that there is a relationship between HPV infection and can-
cers of the head and neck. Many studies of the frequency of HPV in 
head and neck cancers reported 34.5% as a positive result (5). How-
ever, the localization of a certain tumor group varies widely, between 
7% and 59%, according to method or patient characteristic (6).
In HPV detection and typing, there is increasing interest in the use 
of nucleic acid amplification tests for formalin-fixed paraffin-embed-
ded tissues. The detection of viral nucleic acids in formalin-fixed par-
affin-embedded tissues can be complicated, as a result of excessive 
fixation and long-term secondary viral DNA/RNA degradation. How-
ever, such specimens are useful for HPV detection when fresh or fro-
zen tissue can not be obtained and because most surgical pathology 
specimens are formalin-fixed paraffin-embedded tissues (7). Today, 
HPV detection in formalin-fixed paraffin-embedded tissues is based 
on immunohistochemistry, primarily replacing protein markers and 
in situ hybridization (ISH) for HPV DNA. Immunohistochemical meth-
ods have high sensitivity but low specificity. On the other hand, ISH 
methods are specific but have low sensitivity, and thus, the findings 
can be difficult to assess. Compared to immunohistochemistry and 
ISH, the use of nucleic acid amplification tests provides increased 
analytic sensitivity and specificity and thus can supplement these 
techniques (8). 
The key factor in apoptosis integration with the cell cycle is p-53 pro-
tein, which is a tumor-suppressing gene product (9). Many studies re-
ported mutant p53 protein in larynx SCCs. However, it is controversial 
whether this is an indicator of poor prognosis or not. Some studies 
indicate that the index of tumor suppressor gene protein is related 
to a poor prognosis, whereas others suggest the opposite (10-12).
There is a good correlation between the amount of mitosis in tumor 
tissue and nuclear immunoreactivity of Ki-67, which indicates cell 
proliferation (12). The prognostic importance of cell proliferation is 
controversial in larynx SCCs. The literature includes articles reporting 
that high Ki-67 proliferation index is a bad prognostic indicator (13). 
On the other hand, some studies report no relationship to patient 
survival (11).
This study investigated the presence of HPV in larynx SCCs via an 
immunohistochemical method and the HPV GenoArray test, which 
is a commercial polymerase chain reaction (PCR) array hybridization 
method. In addition, this study presents p53 and Ki-67 expression, 
revealing the relationship of these indicators with the presence of 
HPV and clinicopathological parameters.
Materials and Methods
Patients
This study retrospectively included 47 cases that were operated on 
for larynx SCC at the Otorhinolaryngology Clinic of Adnan Mende-
res University, Turkey. Paraffin block samples obtained from patients 
were chosen from the archive of the Pathology Department, and 
cross-sections of these blocks were tested for immunohistochemis-
try and PCR. Clinical data of the patients were recorded.
Immunohistochemical staining
Hematoxylin and eosin (H&E)-stained preparates of cases were 
re-examined. Cross-sections were chosen from blocks that were 
necrosis-free or those containing minimum necrosis. Immunohisto-
chemical stains were applied to new cross-sections obtained from 
the blocks, including: panHPV [human papilloma virus (HPV) Ab-3 
Thermo MS-1826-R7 (RTU), Type: 6, 11, 16, 18, 31, 33, 42, 51, 52, 
56, 58], HPV-16 [anti-papillomavirus tube 16 (HPV-16) (CamVir-1) 
Biogenex AM362-5M (RTU)], HPV-18 [human papilloma virus 18 E7 
(HPV-18) (Clone 718-15) Thermo MA1-23076], p53 [rabbit anti-hu-
man p53 monoclonal antibody (clone SP5) Spiring MS3056 (RTU)] 
and Ki-67 [rabbit anti-human Ki-67 monoclonal antibody (clone SP6) 
Spiring MS3066 (RTU)]. Immunohistochemical staining was via the 
avidin-biotin complex system. Pursuant to staining, cross-sections 
were examined under an optical microscope (Olympus BX51, Tokyo, 
Japan) at 4×, 10×, 20×, and 40× magnification. Nuclear staining was 
assessed for all immunohistochemical stains. In the most intensely 
stained area, at least 200 cells were found. For Ki-67 and p53, the 
staining percentages were scored as follows: less than 5%: 0; 5-10%: 
+; 11–20%: ++; and more than 20%: +++. For panHPV, HPV-16, and 
HPV-18, semi-quantitative scores were “0” for no staining, “+” for focal 
staining, and “++” for extensive staining. 
HybriBio HPV genoarray test 
For PCR and genotyping, between 10 and 20 leaf cross-sections, 5–10 
microns in thickness, were obtained from paraffin blocks. Specimens 
were tested with a HybriBio HPV GenoArray diagnostic kit (GenoAr-
ray, HybriBio Ltd., Hong Kong). This test kit combines PCR and hybrid-
ization methods and can qualitatively detect 21 types of HPV. The test 
offers a macro-array format, through which HPV genotype-specific 
oligonucleotide probes are immobilized on a plastic membrane (14). 
The sensitivity of the method is 4-89 genome copies/µl and varies 
by HPV genotype. It is also reported that there is no cross-reactivity 
between different HPV types during hybridization (15). A commercial 
NucleoSpin Tissue mini column (Macherey-Nagel, Duren, Germany) 
isolation kit was used for the removal of paraffin from tissue and for 
DNA isolation. Following DNA isolation, HPV typing was conducted 
at three stages: increase of DNA via PCR, hybridization, and assess-
ment of the results. For the increase of HPV DNA with PCR, 23.24 μl 
PCR mix, 0.75 μl DNA Taq polymerase, and 1 μl isolated DNA were 
added to PCR tubes for each specimen, in line with the manufactur-
er’s instructions. PCR tubes that were prepared for the 47 specimens 
were placed in an Eppendorf- brand thermal cycler device for the 
amplification stage. The amplification process consisted of denatur-
ation at 95°C for 9 min with a thermal cycler; then, a program com-
prising 40 cycles at 95°C for 20 sec, at 55°C for 30 sec, and at 72°C for 
30 sec; and a final extension for 5 min at 72°C.
For the hybridization process, square-shaped hybridization mem-
branes were placed in a HybriMax device. A mixture of 0.5 μl heated 
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hybridization buffer and 20 μl PCR products was added to each spec-
imen. Following processes conducted in accordance with the meth-
od, wet membranes were left to dry, and the place of purple dots on 
the membranes was assessed by eye. The accuracy of the test was as-
sessed by the presence of amplification points in the first well of the 
membrane and the dot in the well below, indicating that the hybrid-
ization process was completed. A negative result was determined via 
the presence of amplification and hybridization dots combined with 
a lack of dots on the membranes in the wells. A positive result was 
indicated by the presence of amplification and hybridization dots, 
combined with the occurrence of dot/s according to the localization 
of 21 HPV types (the kit includes high-risk group: HPV-16, 18, 31, 33, 
35, 39, 45, 51, 52, 56, 58, 59, 66, 68 and low-risk group: 6, 11, 42, 43, 
44, 53, and CP8304). 
Statistical analysis
In the test for Ki-67 and p53, staining between 0% and 10% was con-
sidered low grade, and >10% was considered high-grade staining. 
In the examination of PanHPV, HPV-16, and HPV-18, focal and exten-
sive staining was considered positive; those without staining were 
considered negative. 
Statistical analysis was conducted with Statistical Package for the So-
cial Sciences (SPSS Inc., Chicago, IL, USA), version 14.0 for Windows. 
Definitive statistics used number and percentages; intergroup com-
parisons used chi-square and Fisher’s exact test, and comparisons 
between dependent groups used the McNemar test. A p-value <0.05 
was considered to be significant. 
Results
Clinical and pathologic data of the cases are presented in Table 1. 
In the p53 staining via the immunohistochemical method, low-grade 
staining was detected in 22 (46.8%) cases, and high-grade staining 
was detected in 25 (53.2%) cases. No significant difference was found 
between p53 and smoking (p=0.611), tumor localization (p=0.927), 
neck metastasis (p=0.790), T phase (p=0.381), panHPV staining 
(p=0.053), HPV-16 staining (p=0.163), and Ki-67 staining (p=0.210). 
Histological grade showed that as differentiation decreased, p53 ex-
pression increased (p=0.041).
In the immunohistochemical Ki-67 staining, low-grade staining was 
detected in 19 (40.4%) cases, and high-grade staining was detected in 
28 (59.6%) cases. No significant difference was found between Ki-67 
and smoking (p=0.137), tumor localization (p=0.990), neck metastasis 
(p=1.00), histological grade (p=0.439), and T phase (p=1.000). When 
comparing Ki-67 and panHPV (p=0.004) and HPV-16 (p=0.002) stain-
ing, the expression of Ki-67 was higher in positive cases (Figure 1).
In panHPV staining via the immunohistochemical method, nega-
tive staining was detected in 25 (53.2%) cases, and positive staining 
was detected in 22 (46.8%) cases. In the HPV-16 staining, negative 
staining was detected in 27 (57.4%) cases, and positive staining was 
detected in 20 (42.6%) cases. None of the patients showed positive 
Figure 1. a-d. Low- (a) and high-grade (b) immunohistochemical 
staining with p53; low- (c) and high-grade (d) immunohistochemical 
staining with Ki-67
a
c
b
d
Figure 2. a-d. Immunohistochemical staining with panHPV: focal (a) and 
extensive (b); immunohistochemical staining with HPV-16: focal (c) and 
extensive (d)
a
c
b
d
Table 1. Clinical and pathologic data of cases
Gender 1 Female (2.1%)
 46 Males (97.9%)
Smoking 43 smokers (91.5%)
 4 non-smokers (8.5%)
Histological grade 20 good differential  (42.6%)
 22 medium differential (46.8%)
 5 low differential (10.6%)
Tumor localization 7 supraglottic (14.9%)
 20 transglottic (42.6%)
 20 glottic (42.6%)
TNM staging 15 T1 (31.9%)
 11 T2 (23.4%)
 5 T3 (10.6%)
 16 T4 (34%)
Lymph node involvement 12 metastases (25.5%)
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HPV-18 staining via the immunohistochemical method. In the pan-
HPV and HPV-16 staining, no significant relationship was detected 
between smoking (p=0.894, p=0.458), tumor localization (p=0.620, 
p=0.587), neck metastasis (p=0.797, p=0.517), histological grade 
(p=0.666, p=0.761), and T phase (p=0.491, p=0.528). A significant 
difference was detected between panHPV and HPV-16 staining; all 
cases stained with HPV-16 were also stained with panHPV (Figure 2).
Polyclonal HPV positivity was detected in 15 (31.9%) cases via the 
PCR array hybridization method. HPV-16 was detected in 5 (10.6%) 
cases, HPV-31 was detected in 1 (2.1%), HPV-52 was detected in 1 
(2.1%) case, HPV-53 was detected in 5 (10.6%) cases, HPV16 and 
HPV-5 were detected in 1 (2.1%) case, and HPV-16 and HPV-68 were 
detected in 2 (4.3%) cases (Figure 3). No significant difference was 
found between HPV PCR positivity and smoking (p=1.000), tumor 
localization (p=0.318), neck metastasis (p=0.725), histological grade 
(p=0.453), and T phase (p=0.414). Contrary to the literature, HPV-68 
was found in two cases (Table 2).
There was no significant difference between the immunohistochem-
ical panHPV results and HPV (PCR) methods (p=0.143). When com-
paring the HPV16 (PCR) results with immunohistochemical HPV-16 
positivity, a significant difference (p=0.000) was found, and immu-
nohistochemical positivity was observed in cases with HPV-16. HPV-
18 was not detected with these two methods. In HPV (PCR)-positive 
cases, no significant relationship was detected with p53 (p=0.989); 
on the other hand, a statistically significant relationship was detected 
with Ki-67 (p=0.01) staining.
Discussion
Most laryngeal cancers are SCCs (16). In the literature, it is reported 
that 60% of larynx cancers are glottic, 40% is supraglottic, and only 
1% or fewer are subglottic (17). In this study, glottic tumor localiza-
tion (42.6%) was most common. 
Smoking and alcohol consumption are the most important etiologic 
factors in laryngeal cancer (18, 19). Smoking is the most common en-
vironmental factor, both as an initiator and progressor (20). The prev-
alence of smoking is lower among women than men. It is assumed 
that passive smokers bear the same risk, although this has not yet 
been demonstrated (19). Low socio-economic status, laryngeal pap-
illomatosis, and family history are other etiologic factors (18). In this 
study, 91.5% of cases were smokers.
p53 gene is a tumor suppressor gene that weighs 53 kDa and is located 
on the short arm (17p13.1) of chromosome 17. It controls DNA replica-
tion, cell proliferation, and cell death (21). Various human tumors mu-
tate in the p53 gene. This situation leads to increased stability of this 
protein and increased immune staining. However, HPV-related cancers 
generally do not mutate in p53. It is revealed that the E6 protein of HPV 
bonds to p53 and its degradation. Cells that express HPV E6 protein 
can not accumulate significant levels of p53 protein pursuant to DNA 
damage. Therefore, p53 loss of function can be related to mutation, 
similar to HPV-negative head/neck cancers, or can be related to rap-
id degradation, as in HPV-related cervical cancers (22). p53 mutation 
is reported in 39%-80% of head and neck SCCs (9). It is reported that 
excessive p53 expression is related to precancerous and proliferative 
activity in malignant larynx lesions. In addition, it is reported that some 
groups are diagnosed with p53 protein at relatively high frequency in 
precancerous lesions of the larynx (23). These findings suggest there 
are some disconformities in precancerous lesions of the larynx to indi-
cate the importance of p53. Kazkayası et al. (24) reported no significant 
relationship between p53 expression and patient age, tumor location, 
clinical phase, histopathologic grading of tumor, alcohol, and clinical 
progress; they found a significant relationship between excessive p53 
expression and lymph node metastasis. Jacob et al. (25) reported a 
relationship between HPV infection and increased p53 expression in 
larynx SCCs. In this study, no relationship was observed between the 
presence of HPV and p53 staining; however, a significant difference 
was detected in high-grade tumors (p=0.041).
Figure 3. a-f. HybriBio HPV GenoArray test kit, positive (a) and neg-
ative (b) controls. Hybridization membrane HPV type 16 (c), type 52 
(d), type 53 (e), and type 68 (f ) samples
a
c
e
b
d
f
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Table 2. Rate of HPV in cases  
panHPV (immunohistochemistry) 22 positive (46.8%)
 25 negative (53.2)
HPV-16 (immunohistochemistry) 20 positive (42.6%)
 27 negative (57.4%)
HPV (PCR) 15 polyclonal HPV positivity (31.9%)
 32 negative (68.1%)
HPV (PCR) Distribution 5 HPV-16 (10.6%)
 1 HPV-31 (2.1%)
 1 HPV-52 (2.1%)
 5 HPV-53 (10.6%)
 1 HPV-16 and HPV-52 (2.1%)
 2 HPV-16 and HP-68 (4.3%)
HPV: human papillomavirus; PCR: polymerase chain reaction
Ki-67 is a nuclear non-histone protein located on chromosome 10. It 
consists of two molecules, weighing 345 kDa and 395 kDa. G1 and G2 
of the cell cycle out of G0 are expressed in the M and S phases (26). 
The importance of cell proliferation in larynx SCCs in the prognosis 
is controversial, because previous studies obtained contradictory re-
sults. Açıkalın et al. (13) found a significant correlation between high 
Ki-67 index and age, T phase, lymph node metastasis, increased re-
currence, and short survival period. In the same study, no significant 
relationship was observed between Ki-67 and tumor localization or 
histopathologic grade (13). Liu et al. (27) reported that high Ki-67 in-
dex correlated with T phase and tumor differentiation and was in-
versely proportional to disease-free survival. In the same study, no 
significant relationship was detected between p53 expression and 
clinicopathologic data, and it was reported that p53 expression had 
no prognostic value. Lera et al. (28) found no relationship between 
clinicopathologic features and the expression of Ki-67 and p53 in lar-
ynx SCC cases; however, they reported that survival was shorter in 
cases with high Ki-67 index and that p53 does not influence survival. 
In the present study, no significant difference was detected between 
Ki-67 expression and clinicopathologic parameters, and no correla-
tion was found with p53 expression (p=0.210). 
The relationship between HPV and upper-airway pathologies has 
been known for approximately 1 century (29). However, in the last 3 
decades, viral oncogenic effects have been better revealed in the liter-
ature (30). It has been found that among forms of head and neck can-
cer, HPV is particularly related to tonsil and oropharyngeal cancers (31). 
The cause-and-effect relationship between HPV and SCCs suggests 
the presence of virus as a risk indicator. The high-risk sub-types of HPV 
are basically HPV16, 18, 31, 33, 39, 45, 52, 58, 68, and 69. These types 
play a role in cervical and other anogenital cancers. HPV-6 and HPV-11 
are “low-risk” types and are rarely found in malignant lesions (16). 
Immunohistochemistry is performed using a commercially available 
monoclonal rat antibody. The test can be used for HPV detection 
during histopathological diagnosis (3). Dönmez et al. (32) detected 
HPV in 37.5% of cases using the immunohistochemical method and 
concluded that the staining was technically difficult. In the present 
study, HPV-16 and HPV-18 antibodies that occurred in the high-risk 
group and panHPV were detected via the immunohistochemical 
method. The resulting positive staining rates were 53.2% with pan-
HPV and 57.4% with HPV-16. No specific staining was detected with 
HPV-18. A significant correlation (p=0.000) was detected between 
panHPV and HPV-16. Immunohistochemistry is a cheaper and easi-
er method of determining the presence of HPV; however, it should 
be remembered that erroneous staining outcomes may occur due to 
technical reasons. 
In the detection of HPV infections, the prevalent approach involves 
the display of viral nucleic acids due to non-advantageous virus iso-
lation or serologic tests (15). Virological tests consist of ISH, Southern 
blot hybridization, dot-blot hybridization, PCR, and real-time PCR. 
However, the detection power of ISH is low. In addition, PCR and re-
al-time PCR require specific expensive equipment, such as a thermal 
cycler, and these methods are not yet common in hospital labora-
tories (33). The HybriBio GenoArray test used in this study is a com-
mercial kit that has recently increased in popularity. At the present 
time, it is used in China, and there are studies supporting its value in 
high-risk HPV detection (4). 
The argument in HPV typing methods results from the lack of a con-
firmed method for HPV genotyping in formalin-fixed paraffin-em-
bedded tissues. Some methods require special instruments and may 
not be easily applied in molecular pathology and molecular virology 
laboratories (34). Recently, various methods have been developed to 
present HPV types in wide panels. To date, these methods have only 
been used in studies in the USA, and it is seen that they have primary 
benefits for epidemiological studies of HPV infection (8). 
Morshed et al. (35) used the PCR method to investigate HPV DNA in 
paraffin and fresh-frozen tissues in 54 larynx SCCs. They found that 
paraffin tissues can be used for HPV DNA detection in retrospective 
studies (35). Gorgoulis et al. (36) detected HPV positivity in 20 (13%) 
of 154 larynx SCC cases. They detected HPV-6 (1.1%) in 1 case, HPV-
16 (16.2%) in 12 cases, HPV-18 (2.2%) in 2 cases, and HPV-33 (1.1%) 
in 1 case. In the present study, HPV DNA isolation of paraffin tissues 
was made, and typing was conducted with the GenoArray hybridiza-
tion method. Using the PCR method, polyclonal HPV positivity was 
detected only in 15 (31.9%) cases. HPV-16 was detected in 5 (10.6%) 
cases, HPV-31 was detected in 1 (2.1%) case, HPV-52 was detected in 
1 (2.1%) case, HPV-53 was detected in 5 (10.6%) cases, HPV-16 and 
HPV-52 were detected in 1 (2.1%) case, and HPV-16 and HPV-68 were 
detected in 2 (4.3%) cases. Having previously been categorized as 
medium-risk, HPV-68 has been reclassified in the high-risk group in 
recent years. Within the literature, no HPV-68 virus was detected in 
larynx SCCs until recently.
Morshed found a 35.5% prevalence of HPV DNA with PCR in 93 
laryngeal SCC cases, and staining was 27.7% with immunohisto-
chemistry in 130 cases. In HPV detection, no correlation was found 
between the PCR method and immunohistochemical technique. 
PCR was recommended as the most sensitive method of HPV de-
tection (3). In the present study, no significant difference was found 
between panHPV staining and the PCR results. However, a correla-
tion (p=0.000) was detected between HPV-16 presence that was 
detected with PCR and HPV16 positivity detected immunohisto-
chemically. Deilson et al. (16) detected high-risk HPV in 37.3% of 
110 larynx SCC cases, HPV-16 in 37% of cases, and HPV-18 in 44% 
of cases. In the same study, p53 positivity was found in 78.2% of 
cases. It is remarkable that these cases had a high grade and high 
Ki-67 index (16). In the present study, high-grade Ki-67 staining was 
observed in cases with panHPV (p=0.004) and HPV-16 (p=0.002) 
positivity. In addition, Ki-67 staining was significantly high in cases 
with HPV (PCR) positivity (p=0.01). 
The relationship between HPV and larynx cancer has not yet been 
clarified. Challenges in HPV detection and typing may result from 
temporary infections, patched involvement, and the various meth-
ods used in studies on the presence of HPV and from the differing 
sensitivities of these methods. Immunohistochemical detection of 
HPV is a cheap and easy method that can utilize tumor tissues. Al-
though it has some weaknesses, such as subjective assessment and 
potentially erroneous results due to technical conditions, it remains a 
good supplementary test for the presence of HPV. For HPV detection, 
the gold standard method is to study HPV DNA with PCR on fresh 
tissue; however, paraffin-embedded tissues can also be used to indi-
cate the presence of HPV. The use of the HybriBio HPV GenoArray test 
has increased in recent years; it is much simpler than other methods 
and can be a valuable tool to detect HPV-DNA. 
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It is hoped that further HPV studies on larger datasets using standard 
methods will give more definitive results. Identifying the presence of 
HPV will shed light on the prevention of laryngeal cancers and assist 
in HPV vaccination activities.
In the literature, it is not clear how the expression of p53 and Ki-67 
affects the prognosis in larynx carcinoma. In the present study, it is 
assumed that the relationship between high grade and high-grade 
p53 expression can be an indicator of the poor prognosis of p53 ex-
pression. In HPV-positive cases, Ki-67 staining was significantly high-
grade. The expression of Ki-67 and p53 could be central to a good 
or poor prognosis in laryngeal SCCs. Further studies are required to 
better understand the importance of these parameters for the treat-
ment and follow-up of laryngeal SCCs.
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